Raffaella Marcheselli
Modena, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
A phase 2 study of autologous stem cell transplantation as salvage therapy for older patients with aggressive B-cell lymphoma prospectively evaluated by comprehensive geriatric assessment: the FIL_RECANZ study.
Journal: Leukemia & lymphoma
Published: March 08, 2025
The FGF/FGFR/c-Myc axis as a promising therapeutic target in multiple myeloma.
Journal: Journal of experimental & clinical cancer research : CR
Published: August 19, 2024
Correction to: The classic prognostic factors in advanced Hodgkin's lymphoma patients are losing their meaning at the time of pet-guided treatments.
Journal: Annals of hematology
Published: November 21, 2020
Cell of origin (COO), BCL2/MYC status and IPI define a group of patients with Diffuse Large B-cell Lymphoma (DLBCL) with poor prognosis in a real-world clinical setting.
Journal: Leukemia research
Published: November 11, 2020
Impact of body composition, nutritional and inflammatory status on outcome of non-small cell lung cancer patients treated with immunotherapy.
Journal: Clinical nutrition ESPEN
Published: October 20, 2020
NEAT1: a multifaceted long non-coding RNA in multiple myeloma.
Journal: Haematologica
Published: September 10, 2020
Improving the international prognostic index score using peripheral blood counts: Results of a large multicenter study involving 520 patients with diffuse large B cell lymphoma.
Journal: Hematological oncology
Published: February 26, 2020
The classic prognostic factors in advanced Hodgkin's lymphoma patients are losing their meaning at the time of Pet-guided treatments.
Journal: Annals of hematology
Published: April 08, 2019
The prognostic role of end of treatment FDG-PET-CT in patients with diffuse large B cell lymphoma can be improved by considering it with absolute monocyte count at diagnosis.
Journal: Leukemia & lymphoma
Published: January 29, 2019
Absolute monocyte count at diagnosis could improve the prognostic role of early FDG-PET in classical Hodgkin lymphoma patients.
Journal: British journal of haematology
Published: October 28, 2016
Neutrophil-lymphocyte ratio at diagnosis is an independent prognostic factor in patients with nodular sclerosis Hodgkin lymphoma: results of a large multicenter study involving 990 patients.
Journal: Hematological oncology
Published: August 17, 2016
Last Updated: 09/26/2026